Fundraising Fox
FluoSphera
Geneva, CH · 9 employees on LinkedIn · 4 known investors
Find your way into FluoSphera
Sign up to see every warm intro you have to FluoSphera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FluoSphera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FluoSphera develops in vitro human biology solutions for drug discovery, applying translational research to improve preclinical decision-making. The company serves pharmaceutical and biotech organizations seeking more predictive biological models.
Founders & leadership
CB
Clélia BourgointCEO, Chair & Co-FounderClélia Bourgoint holds an engineering degree from ESBS Strasbourg and a PhD in Biology from the University of Geneva, with training across molecular biology, structural biology, protein biochemistry, and enzymology. She is CEO, Chair, and Co-Founder of FluoSphera, which develops in vitro human biology solutions for drug discovery.
GS
Gregory SegalaCSO & Co-FounderGregory Segala is co-founder and chief scientific officer of FluoSphera, which develops multi-tissue in vitro models using microfluidics and imaging for drug discovery. He co-invented the underlying technology during the iGEM competition in 2019.
AR
Aurélien RouxScientific Advisor & Co-Founder
Investors · 4
SOSVlisted by SOSVNew York · $30K – $550K
How we know: a partner's Signal profile · sosv.com · Not right? Tell us
Soulmates Ventureslisted by Soulmates VenturesPrague · $3M
How we know: Soulmates Ventures's portfolio page · funding news · Not right? Tell us
IndieBioreportedSan Francisco · $525K
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseedJan 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does FluoSphera do?
- FluoSphera develops in vitro human biology solutions for drug discovery, applying translational research to improve preclinical decision-making. The company serves pharmaceutical and biotech organizations seeking more predictive biological models.
- Who founded FluoSphera?
- FluoSphera was founded by Clélia Bourgoint, Gregory Segala, Aurélien Roux.
- Who are FluoSphera's investors?
- FluoSphera's investors include SICTIC, SOSV, Soulmates Ventures, IndieBio.
- Where is FluoSphera headquartered?
- FluoSphera is headquartered in Geneva, CH.